Literature DB >> 7026097

HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies.

G Ballardini, P Landi, C A Busachi, F B Bianchi, E Pisi.   

Abstract

To test the hypothesis that LKM antibodies are directed against antigen(s) of the smooth endoplasmic reticulum, liver biopsies from patients with HBsAg chronic hepatitis, rich in liver cells with HBsAg-induced hypertrophic SER, were used. A close correspondence was seen between cells with HBsAg-positive cytoplasm by immunoperoxidase and cells with a stronger and more homogeneous fluorescence by indirect immunofluorescence with LKM-positive sera. These results point to antigenic components of SER as reacting with LKM antibodies. The relevance of antigens present in the ribosomes and membranes of rough endoplasmic reticulum needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026097      PMCID: PMC1537195     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  The immunoelectron-microscopical demonstration of antibodies against endoplasmic reticulum (microsomes) in chronic aggressive hepatitis and liver cirrhosis.

Authors:  W Storch; L Cossel; R Dargel
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  Characterization of the microsomal antigen related to a subclass of active chronic hepatitis.

Authors:  M Rizzetto; F B Bianchi; D Doniach
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

3.  Microsomal antibodies in active chronic hepatitis and other disorders.

Authors:  M Rizzetto; G Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

Review 4.  Immunopathology of hepatitis B.

Authors:  L Bianchi; F Gudat
Journal:  Prog Liver Dis       Date:  1979

5.  Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate.

Authors:  F B Bianchi; P L Penfold; I M Roitt
Journal:  Br J Exp Pathol       Date:  1973-12

6.  Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus.

Authors:  F B Bianchi; M Rizzetto; P Penfold; G T Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

7.  An immunoperoxidase technique for demonstrating membrane localized HBsAg in paraffin sections of liver biopsies.

Authors:  C A Busachi; M B Ray; V J Desmet
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

8.  Hepatic disorders associated with liver-kidney microsomal antibodies.

Authors:  M G Smith; R Williams; G Walker; M Rizzetto; D Doniach
Journal:  Br Med J       Date:  1974-04-13
  8 in total
  4 in total

1.  Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).

Authors:  M Lenzi; F B Bianchi; F Cassani; E Pisi
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

2.  Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue.

Authors:  A Kyriatsoulis; M Manns; G Gerken; A W Lohse; W Ballhausen; K Reske; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

3.  Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations.

Authors:  L Fabris; M Strazzabosco; H A Crosby; G Ballardini; S G Hubscher; D A Kelly; J M Neuberger; A J Strain; R Joplin
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

4.  Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum.

Authors:  F Alvarez; O Bernard; J C Homberg; G Kreibich
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.